Authors: J. McCall, H. Hobbs, C. Ranger, F. Cameron, H. Stuart, J. Nelken, J. Majalahti, K. Urbanoski, G. Kolla, J. LeMaistre, K. Toombs, R. Herriot & Bernie Pauly
This article examines prescription safer supply programs and their ability to reduce overdoses, especially during public health emergencies like the Covid-19 pandemic.